Levocetirizin Actavis

Levocetirizine, the active ingredient in Levocetirizin Actavis, is an antihistamine presented as an oral tablet for systemic use. It reduces symptoms of allergic rhinitis and chronic idiopathic urticaria in adults and children as directed by a healthcare professional.

GNH USA supplies Levocetirizin Actavis as a licensed, GDP‑compliant international pharmaceutical supplier, providing the product to hospitals, pharmacies and clinics worldwide from its EU‑sourced manufacturing network. Our distribution ensures consistent quality and regulatory adherence across global markets.

Levocetirizine is an antihistamine that targets histamine‑mediated allergic conditions.

Allergic rhinitis (seasonal or perennial): alleviates nasal congestion, sneezing, itching and rhinorrhea. Chronic idiopathic urticaria: decreases the frequency and severity of hives and associated itching. Allergic conjunctivitis: helps reduce eye itching and redness caused by histamine release.

Levocetirizine is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Drowsiness or mild sedation - Fatigue or feeling of tiredness - Dry mouth - Headache - Nausea - Abdominal discomfort

Serious or Rare Side Effects: - Angioedema or swelling of the face, lips or tongue - Anaphylactic reactions - Severe skin reactions such as Stevens‑Johnson syndrome - Tachycardia or irregular heartbeat - Hepatic dysfunction - Blood dyscrasias including neutropenia or thrombocytopenia

Before initiating therapy, consider the following precautions.

Pregnancy: consult a healthcare provider to assess risk‑benefit. Breastfeeding: evaluate potential exposure to the infant. Renal impairment: dose adjustment may be required in reduced kidney function. Elderly patients: monitor for increased sedation or confusion. Drug interactions: review concomitant medications for possible additive effects. Store at ambient temperature: keep below 25 °C, retain in the original packaging, and protect from moisture.

Levocetirizine may interact with several medicines; categorize them as follows.

Major Interactions (Avoid): - Alcohol: can enhance sedation and drowsiness. - Central nervous system depressants (e.g., benzodiazepines, opioids): additive sedative effect. - Antifungal ketoconazole: may increase plasma concentrations of levocetirizine.

Moderate Interactions (Monitor Closely): - Ritonavir: potential increase in exposure. - Theophylline: possible reduction in clearance. - Macrolide antibiotics (e.g., erythromycin): may affect metabolism and plasma levels.